HOME >> BIOLOGY >> NEWS
New Guidelines To Improve Public Understanding

February 27, 1998, WASHINGTON, DC -- Feeling more confused than enlightened after reading or hearing about the latest dietary study du jour? Newly-released guidelines, based on an advisory group convened by the Harvard School of Public Health and the International Food Information Council (IFIC) Foundation, aim to help the public have a better understanding of emerging nutrition, food safety and health science.

"Improving Public Understanding: Guidelines for Communicating Emerging Science on Nutrition, Food Safety and Health" suggests both broad and specific "guiding principles" for those involved in communicating emerging science, from scientists and journal editors to public information officers, journalists, and industry, consumer and other interest groups.

"There is no expectation that every story will include all or most of the suggested information. Instead these guidelines can help communicators focus on the most vital information the public should have in order to form the most useful net impression of a particular study's findings," said Harvey V. Fineberg, MD, PhD, MPH, provost of Harvard University and Sylvia Rowe, president of the IFIC Foundation, co-authors of a commentary published in a recent issue of the Journal of the National Cancer Institute (JNCI).

As one of the key participants in the advisory group, ABC-News' Dr. Timothy Johnson commented, "I think what the public wants is for us to be honest with each study as it comes along and try to put it into perspective, but keep reminding people that it's the totality of evidence as it unfolds that warrants their attention."

In addition to publication in JNCI (2/4/98), the guidelines were reported in the Journal of the American Medical Association (JAMA, 2/11/98).

Reprints of the JNCI article and JAMA report and a booklet version of "Improving Public Understanding: Guidelines for Communicating Emerging Science on Nutrition, Food Safety, and Health" are available from
'"/>

Contact: Amelia Steiner, Kara Cosby, Alison Esser
esser@ific.health.org
202/296-6540
International Food Information Council Foundation
24-Mar-1998


Page: 1 2

Related biology news :

1. Guidelines outline evaluation of children with global developmental delay
2. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
3. Guidelines For Next Generation Of Environmental Policy
4. Guidelines For Human Germ-Line Interventions Topic Of AAAS Forum
5. Improved nutrition could reduce malaria burden worldwide
6. Improved nutrition could prevent more than half of the worlds child deaths annually
7. Improved crop production and fewer greenhouse gases
8. Improved medical treatment of serious heart problems focus of UH-led group
9. Improved estimates of population extinction risk (Harding and McNamara)
10. Improved guidance systems for missiles will reduce collateral damage
11. Food allergy reactions in schools: Improvements needed to reduce and respond

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Guidelines Improve Public Understanding

(Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
(Date:4/10/2015)... , April 10, 2015 ... addition of the "Security Competitive Profiles - NEC" ... http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to supply ... to the market, with a company focus on the ... anticipated. Winning opportunities in the ...
(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
(Date:4/21/2015)... April 21, 2015 The North ... in 2014 to $605.1 million by 2019, at a ... Browse through the TOC of North ... of the industry trends and segments, with help of ... Early buyers will receive 10% customization ...
(Date:4/21/2015)... , April 21, 2015 Merrimack Pharmaceuticals, ... from a multi-arm Phase 1 study of MM-141, a ... presented in an oral session by Dr. Mansoor ... Cancer Research Annual Meeting in Philadelphia, PA. ... of MM-141 as a monotherapy and in combination with ...
(Date:4/21/2015)... PROVO, Utah , April 21, 2015  Tute Genomics, ... the hiring of Josh Forsythe as VP of ... that has witnessed a significant expansion in its commercial operations ... " Josh Forsythe is a ... Robison , MD MBA, CEO of Tute Genomics. "Josh,s vast ...
(Date:4/21/2015)... York (PRWEB) April 21, 2015 Progyny, ... Fertility Authority, LLC, announced that it has secured additional ... (KPCB), TPG Biotech, SR One and Merck Serono Ventures. ... to provide patients the best fertility outcomes by aligning ... the largest online marketplace for families seeking fertility solutions ...
Breaking Biology Technology:North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 2North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 2Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 3Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 4Announcing Progyny: Combining Best-in-Class Clinical Solutions with Consumer Expertise 2
Cached News: